＜5580＞ Prodelight 1363 +300

A stop high has been added, and the year-to-date high has been updated. It was disclosed on the 9th that a patent related to technology that can analyze human emotions from speech has been obtained, and it continues to be viewed as purchasing material. It is a technology that analyzes human emotions from speech, making it possible to score positive/negative obtained by weighting Prodelight's own for each parameter (normal, joy, anger, sadness, energy). It would be nice if it could be used for state management etc. of employees working in a remote environment

wow.

＜1436＞ GREEN ENA 2139 -291

A sharp decline. Operating profit and loss for the first quarter (24/5/7) of the fiscal year ending 25/4 have been announced as a deficit of 0.017 billion yen (surplus of 0.03 billion yen in the same period last year). Sales secured an increase of 1.979 billion yen, up 1.9% from the same period last year, but sales and administration costs increased due to personnel increases, upfront expenses for the grid storage battery business, an increase in goodwill amortization costs, and an increase in temporary costs associated with holding companies and company name changes, etc. However, as predicted at the beginning of the fiscal year, the full-year operating profit and loss forecast remained unchanged at a surplus of 0.6 billion yen, up 17.1% from the previous fiscal year.

＜2370＞ MDNT 53 +9

Significantly higher. It has been announced that a strategic partnership agreement has been signed with AGC ＜5201＞ in the cell therapy drug CDMO (contract manufacturing of pharmaceuticals, etc., development outsourcing/agency of manufacturing methods) business. In addition to working on the exchange and development of human resources involved in manufacturing and quality between the two companies, Medinet's development and manufacturing capabilities will be complemented at AGC's domestic and international bases. First, AGC will accumulate knowledge in Japan through Medinet's support, and it is said that preparations will proceed for the start of cell therapy drug CDMO services at the Yokohama base.

＜4268＞ Edge Technology 840 +103

Significant increase continued for 5 days. The Tokyo Stock Exchange has expanded the upper limit of the price limit to 600 yen. The lower limit is 150 yen as usual, and the standard price is 737 yen. The high stop is 1337 yen, and the low stop is 587 yen. The Chiba Bank (8331) announced on the 6th that it will carry out a public tender offer (TOB) for 841 yen per share, and the movement towards TOB prices continues. Edge Technology has expressed an opinion in favor, and the company's stock is scheduled to be delisted.

＜4425＞ Kudan 1472 -33

decline. It has been announced that a “self-positioning starter kit NaviStart” for industrial DX will be jointly developed using SLAM (self-position estimation/environmental map creation) technology and local 5G together with HPC Systems ＜6597＞, and sales will begin on 10/1. Target customers are companies considering industrial introduction of remote piloting/autonomous driving solutions using self-positioning in addition to tracking management, productivity improvement/safety enhancement solutions for manufacturing, logistics, construction, agriculture, etc.

＜4811＞ Dream Arts 3045 +200

Significant increase continued for 5 days. It has been announced that collaboration with Fujisoft ＜9749＞ will begin. Achievements related to Dream Arts' main product “SmartDB” were evaluated, and certified as an official partner as a sales partner and cloud integration partner. Also, it is said that “SmartDB Certified Specialist (SCS)” has been certified by Fujisoft as a “self-enlightenment encouragement qualification” that promotes employee ability development as a qualification that contributes to the development of DX human resources.